Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 117.47M | $ 125.02M | $ 86.94M | $ 74.09M | $ 100.46M |
Total Assets | $ 477.43M | $ 466.92M | $ 440.79M | $ 481.54M | $ 349.65M |
Total Debt | $ ― | $ 3.67M | $ ― | $ 5.02M | $ ― |
Net Debt | $ ― | $ -121.35M | $ ― | $ -69.07M | $ ― |
Total Liabilities | $ 267.90M | $ 282.75M | $ 271.66M | $ 318.15M | $ 204.86M |
Stockholders Equity | $ 209.53M | $ 184.17M | $ 169.14M | $ 163.39M | $ 144.79M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |